# Use of Risperidone in ECT for Treatment Resistant Depression

> **NCT00203723** · PHASE4 · TERMINATED · sponsor: **University of California, Los Angeles** · enrollment: 45 (—)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00203723
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 45 (—)
- **Last updated:** 2006-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203723, "Use of Risperidone in ECT for Treatment Resistant Depression". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00203723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*